A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma

Clinical trial NCT02748135 · COMPLETED

Trial details

NCT number: NCT02748135
Sponsor: Oncurious NV
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)

Start date: 2016-05-01
Primary completion: 2020-10-06
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.